Discover hundreds of clinical trials in Connecticut.
Search clinical trials in Connecticut by city, condition or phase.
Connecticut stands out as a prime location for a wide variety of clinical trials, largely thanks to its robust healthcare system and renowned medical research institutions. Leading centers like Yale School of Medicine, UConn Health, and Jackson Laboratory for Genomic Medicine are at the forefront of groundbreaking studies in the state.
Combining a strong focus on innovation and precision medicine makes Connecticut an ideal destination for participants seeking advanced medical treatments and the opportunity to contribute to cutting-edge research.
With a diverse and highly educated population, Connecticut offers distinct advantages for those participating in clinical trials, including the opportunity to enhance the reliability and depth of research findings. The vibrant population here makes clinical studies in Connecticut more comprehensive and representative.
By choosing to participate in a clinical trial in Connecticut, individuals contribute to groundbreaking medical research while benefiting from a well-established and supportive clinical research infrastructure, ultimately advancing healthcare for all.
Connecticut is a hub for cutting-edge medical research, with clinical trials across a diverse array of conditions. Several institutions contribute significantly to advancements in medicine, reflecting the state’s leadership in both academic research and biotech innovation.
Connecticut is a leader in studying rare genetic diseases, with local biotech companies and academic institutions collaborating to research conditions such as cystic fibrosis, Duchenne muscular dystrophy, and other hereditary disorders.
Gene therapy and CRISPR-based gene editing are at the forefront of trials, offering promising solutions that could correct genetic mutations at their source. The state’s focus on personalized medicine in this area positions it as a vital contributor in developing therapies that are patient-specific, with the potential for lifelong disease management or cures.
Heart disease remains a leading cause of death in the U.S., and Connecticut plays a critical role in studying innovative solutions for cardiovascular diseases. Institutions like the UConn Health Center and Hartford HealthCare Heart & Vascular Institute lead clinical trials on heart failure, hypertension, coronary artery disease, and atrial fibrillation.
These trials explore advancements in minimally invasive surgeries, novel medications, and medical devices, such as next-generation pacemakers, designed to improve outcomes and quality of life for patients with chronic heart conditions.
Connecticut is home to prominent cancer research institutions, such as the Yale Cancer Center, which conducts pioneering clinical trials for various types of cancer, including breast cancer, lung cancer, melanoma, and hematological malignancies like leukemia and lymphoma.
The focus for researchers in Connecticut is not only on traditional chemotherapy but also on immunotherapy, targeted therapies, and personalized medicine approaches. This research aims to provide treatments tailored to individual patients' genetic profiles, offering more effective and less invasive options.
Connecticut's focus on neurological diseases like Alzheimer's, Parkinson’s disease, multiple sclerosis (MS), and epilepsy puts it at the forefront of efforts to tackle these complex conditions. Research centers such as Yale School of Medicine run clinical trials aimed at finding new treatments that can slow disease progression or improve early detection through advanced imaging and biomarkers.
Cognitive therapies, neurostimulation techniques, and new pharmacological agents are being tested to manage symptoms and extend patient functionality.
In Connecticut, clinical trials are regulated by both federal and state guidelines to ensure the safety and ethical treatment of participants. Federal oversight is provided primarily by the Food and Drug Administration (FDA) and the Office for Human Research Protections (OHRP), ensuring that all clinical trials comply with national standards for informed consent, ethical treatment, and patient safety.
Trials must also be reviewed and approved by an Institutional Review Board (IRB), which evaluates the study's protocol to ensure that it meets ethical guidelines, protects participants, and balances risks and benefits.
Connecticut-specific regulations may include additional oversight from state health departments, particularly when it comes to the use of investigational drugs or devices. Researchers conducting trials must follow the Connecticut General Statutes that regulate healthcare practices and patient rights, ensuring compliance with local laws governing clinical research.
Taking part in a clinical trial provides the unique opportunity to access new and innovative treatments before they are approved and widely available. This can be especially valuable for those with conditions that have not responded to standard therapies. Participants can benefit from expert medical care, with dedicated healthcare professionals offering close monitoring and individualized attention throughout the trial process.
Moreover, participating in clinical trials plays a vital role in advancing medical science, often leading to major breakthroughs in treatments and therapies. By enrolling, individuals not only gain early access to cutting-edge care but also help shape the future of healthcare, contributing to better outcomes for future patients.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
Sponsor:
Weill Medical College of Cornell University
Location:
Code:
NCT04124120
Conditions
Heart Diseases
Coronary Artery Disease
Coronary Artery Bypass Grafting
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Single arterial graft
Multiple arterial grafting
Sponsor:
Hartford Hospital
Location:
Code:
NCT00282620
Conditions
Arrhythmia
Quality of Life
Hypomagnesemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Magnesium L-lactate
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT03155620
Conditions
Advanced Malignant Solid Neoplasm
Ann Arbor Stage III Non-Hodgkin Lymphoma
Ann Arbor Stage IV Non-Hodgkin Lymphoma
Histiocytic Sarcoma
Juvenile Xanthogranuloma
Eligibility Criteria
Sex: All
Age: 12 - 21
Healthy Volunteers: Not accepted
Interventions
Biopsy
Biospecimen Collection
Bone Marrow Aspiration and Biopsy
Bone Scan
Computed Tomography
Sponsor:
Memorial Sloan Kettering Cancer Center
Location:
Code:
NCT05429320
Conditions
Non-small Cell Lung Cancer
Metastatic Non Small Cell Lung Cancer
Nsclc
NSCLC Stage IV
Minimal Residual Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Local ablative therapy
Blood collection to assess for ctDNA
Sponsor:
VA Office of Research and Development
Location:
Code:
NCT06004804
Conditions
Chronic Musculoskeletal Pain
Eligibility Criteria
Sex: All
Age: 60 - 70+
Healthy Volunteers: Not accepted
Interventions
Emotional Awareness and Expression Therapy
Mindfulness Meditation
Cognitive Behavioral Therapy
Sponsor:
Alexion Pharmaceuticals, Inc.
Location:
Code:
NCT06079372
Conditions
Hypophosphatasia
Eligibility Criteria
Sex: All
Age: 2 - 11
Healthy Volunteers: Not accepted
Interventions
ALXN1850
asfotase alfa
Sponsor:
VA Office of Research and Development
Location:
Code:
NCT05327504
Conditions
Substance Use Disorders
Posttraumatic Stress Disorder
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Written Exposure Therapy
Neutral Topic Writing
Sponsor:
Cerevel Therapeutics, LLC
Location:
Code:
NCT04958031
Conditions
Apathy in Dementia
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
CVL-871 1.0 mg
CVL-871 3.0 mg
Placebo
Sponsor:
Janssen Research & Development, LLC
Location:
Code:
NCT05250973
Conditions
Amyloidosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Daratumumab
Cyclophosphamide
Bortezomib
Dexamethasone